Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone

Cytokine

Volumn 10, Issue 5, 1998, Pages 361-369

  Lubberts, Erik ^a   Joosten, Leo A B ^a   Helsen, Monique M A ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arthritis; Cartilage; IL 10; IL 4; Inflammation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BACTERIAL ARTHRITIS; CARTILAGE DEGENERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS; SYNOVIAL FLUID; SYNOVIUM;

EID: 0032077324     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0298     Document Type: Article

References (51)

1. 2. Proc Natl Acad Sci USA 86:3803-3807.
2. 2. Vannier E, Miller LC, Dinarello CA (1992) Coordinated anti-inflammatory effects of interleukin-4: IL-4 suppresses IL-1 prodution but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc Natl Acad Sci USA 89:4076-4080.
3. 3. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits the cytokine prodution by activated macrophages. J Immunol 147:3815-3822.
4. 4. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
5. 5. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. J Biol Chem 270:9558-9563.
6. 6. Collota F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
7. 7. Cope AP, Gibbons DL, Aderka D (1993) Differential regulation of tumor necrosis factor receptor (TNF-R) by IL-4: upregulation of p55 and p75 TNF-R on synovial joint mononuclear cells. Cytokine 3:205-208.
8. 8. Jenkins JK, Malyak M, Arend WP (1994) The effect of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res 13:47-54.
9. 9. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179:1695-1699.
10. 10. Arend PM, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160.
11. 11. Bucala R, Ritchlin C, Winchester R, Cerami A (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblast. J Exp Med 173:569-574.
12. 12. Elliot MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen J, Leeb B, Breedveld EC, Macfarlane JD, Bijl H, Woody JN (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110.
13. 13. Rankin ECC, Choy EHS, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, Panayi GS (1995) The therapeutic effects of an engineered human anti-tumour necrosis factor α antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 34:334-342.
14. 14. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M (1994) Immuno regulatory role of interleukin-10 (IL-10) in rheumatoid arthritis. J Exp Med 179:1517-1527.
15. 15. Llorente L, Richaud-Patin Y, Kior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647-1655.
16. 16. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davies LS, Fujita K, Lipsky PE (1995) Elevated interleukin-10 levels in patient with rheumatoid arthritis. Arthritis Rheum 38:96-104.
17. 17. Cohen SBA, Katsikis PD, Chu C-Q, Thomssen H, Webb LMC, Maini RN, Londei M, Feldmann M (1995) High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 38:946-952.
18. 18. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P. (1995) Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154:1432-1439.
19. 19. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J (1996) Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 39:386-395.
20. 20. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM (1993) Suppression of monocyte function and differential regulation of IL-1 and IL-1Ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344-4351.
21. 21. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95:2868-2876.
22. 22. Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, Van den Berg WB (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40:249-260.
23. 23. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M (1996) Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39:495-503.
24. 24. Van den Broek MF, van den Berg WB, van de Putte LBA, Severijnen AJ (1988) Streptococcal cell wall induced arthritis and flare-up reactions in mice induced by homologous and heterologous cell walls. Am J Pathol 133:139-149.
25. 25. Van den Berg WB, Joosten LAB, Helsen MA, Van Lent PLEM, Van de Loo FAJ (1994) Cytokine profile dependent on the type of arthritis: dominant role of IL-1 in cartilage destruction. Arthritis Rheum 37 (Suppl. 9):S208.
26. 26. Schwab JH, Brown RR, Anderle SK, Schlievert PM (1993) Superantigen can reactivate bacterial cell wall induced arthritis. J Immunol 150:4151-4159.
27. 27. Dechanet J, Taupin J, Chomarat P, Rissoan M, Moreau J, Banchereau J, Miossec P (1994) Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 24:3222-3228.
28. 28. Dechanet J, Rissoan MC, Banchereau J, Miossec P (1995) Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes. Cytokine 7:176-183.
29. 29. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ (1995) Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 84:536-542.
30. 30. Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M (1995) Interleukin-10 cooperates with interleukin-4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 22:2020-2026.
31. 31. Chomarat P, Banchereau J, Miossec P (1995) Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 38:1046-1054.
32. 32. Van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829-835.
33. 33. Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, de Boer M, Goldman M (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24:1007-1009.
34. 34. Van de Loo AAJ, Arntz OJ, Otterness IG, van den Berg WB (1992) Protection against cartilage proteoglycan synthesis inhibition by anti-interleukin-1 antibodies in experimental arthritis. J Rheumatol 19:348-356.
35. 35. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB (1995) Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum 38:164-172.
36. 36. Yeh L, Augustine AJ, Lee P, Riviere LR, Sheldon A (1995) Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage expiants. J Rheumatol 22:1740-1746.
37. 37. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA (1995) A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499.
38. 99mTc-pertechnetate uptake. Agents Actions 11:640-642.
39. 39. Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE (1989) Deravation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 142:800-807.
40. 40. Schlaak JF, Schmit E, Huls C, Meyer zum Buschenfelde KH, Fleischer B (1994) Sensitive and specific bioassay for the detection of human interleukin-10. J Immunol Methods 168:49-54.
41. 41. Jacobs MJM, Van den Hoek AEM, Van Lent PLEM, Van de Loo AJJ, Van de Putte LBA, Van den Berg WB (1994) Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 83:390-396.
42. 42. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M (1994) Continuous administration of anti-interleukin-10 antibodies delays the onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310.
43. 43. Van den Berg WB, Kruijsen MWM, van den Putte LBA (1982) The mouse patella assay: an easy method of quantitating articular cartilge chondrocyte function in vivo and in vitro. Rheumatol Int 1:165-169.
44. 44. Drenth JPH, van Uum SHM, van Deuren M, Pesman GJ, van der VenJongekrijg J, van der Meer JWM (1995) Endurance run increases circulating IL-6 and IL-1Ra but downregulates ex vivo TNFα and IL-1β production. J Appl Physiol 79:1497-1503.
45. 45. Van den Berg WB, Joosten LAB, Van de Putte LBA (1982) Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice. J Clin Invest 74:1850-1859.
46. 46. Joosten LAB, Helsen MMA, Van de Loo AJJ, Van den Berg WB (1996) Anti-cytokine treatment of established collagen type II arthritis in DBA/1 mice: A comparative study using anti-IL-1 alpha, beta and IL-1Ra. Arthritis Rheum 5:797-809.
47. 47. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 162:156-159.
48. 48. Nasrin N, Colanil E, Denaro M, Kong XF, Kang I, Alexander M (1990) An insulin response element in the glyceraldehyde-3-phophate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells. Proc Natl Acad Sci USA 87:5273-5277.
49. 49. Montgomery RA, Dallman PS (1991) Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 147:554-560.
50. 50. Chensue SW, Bienkowski M, Eessalu TE, Warmington KS, Hershey SD, Lukacs NW, Kunkel SL (1993) Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J Immunol 151:3654-3662.
51. 51. Murray LJ, Lee R, Martens C (1990) In vivo cytokine expression in T-cell subset of the autoimmune MRL/MP-1pr/1pr mouse. Eur J Immunol 20:163-170.